Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/5324
Title: Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer
Authors: Kartal Yandım, Melis
Apohan, Elif
Baran, Yusuf
Kartal Yandım, Melis
Apohan, Elif
Baran, Yusuf
Izmir Institute of Technology. Molecular Biology and Genetics
Keywords: Cancer therapy
Ceramides
Drug resistance
Glucosylceramide synthase
Sphingolipid
Issue Date: Jan-2013
Publisher: Springer Verlag
Source: Kartal Yandım, M., Apohan, E., and Baran, Y. (2013). Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer. Cancer Chemotherapy and Pharmacology, 71(1), 13-20. doi:10.1007/s00280-012-1984-x
Abstract: Sphingolipids including ceramides and its derivatives such as ceramide-1-phosphate, glucosylceramide (GlcCer), and sphingosine-1-phosphate are essential structural components of cell membranes. They now recognized as novel bioeffector molecules which control various aspects of cell growth, proliferation, apoptosis, and drug resistance. Ceramide, the central molecule of sphingolipid metabolism, generally mediates anti-proliferative responses such as inhibition of cell growth, induction of apoptosis, and/or modulation of senescence. There are two major classes of sphingolipids. One of them is glycosphingolipids which are synthesized from the hydrophobic molecule, ceramide. GlcCer, generated by glucosylceramide synthase (GCS) that transfers the glucose from UDP-glucose to ceramide, is an important glycosphingolipid metabolic intermediate. GCS regulates the balance between apoptotic ceramide and antiapoptotic GlcCer. Downregulation or inhibition of GCS results in increased apoptosis and decreased drug resistance. The mechanism underlying the drug resistance which develops with increased glucosylceramide expression is associated with P-glycoprotein. In various types of cancers, overexpression of GCS has been observed which renders GCS a good target for the treatment of cancer. This review summarizes our current knowledge on the structure and functions of glucosylceramide synthase and glucosylceramide and on the roles of glucosylceramide synthase in cancer therapy and drug resistance. © 2012 Springer-Verlag Berlin Heidelberg.
URI: http://doi.org/10.1007/s00280-012-1984-x
http://hdl.handle.net/11147/5324
ISSN: 0344-5704
Appears in Collections:Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File Description SizeFormat 
5324.pdfİnceleme (Review)341.98 kBAdobe PDFThumbnail
View/Open
Show full item record

CORE Recommender

SCOPUSTM   
Citations

34
checked on Jul 24, 2021

WEB OF SCIENCETM
Citations

32
checked on Jul 24, 2021

Page view(s)

12
checked on Jul 24, 2021

Download(s)

24
checked on Jul 24, 2021

Google ScholarTM

Check

Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.